Rockville, MD (PRWEB) October 13, 2005
The Production Assistance for Cellular Therapies (PACT) Group announces its participation in a session at the Annual AABB Meeting at Washington State Convention and Trade Center in Seattle, WA. The program is scheduled for Tuesday, October 18, 2005, 2:00-5:30 pm in Room 606. Technical discussions on products currently being manufactured at PACT facilities will be presented, along with how to apply for manufacturing.
Presentation topics and speakers will include the following:
- Opening and Session Moderator, Jeffrey McCullough, M.D., American Red Cross Chair, Transfusion Medicine, Director, Biomedical Engineering Institute, University of Minnesota
- Background and Rationale for Establishing PACT,
Traci Heath Mondoro, Ph.D., PACT Project Officer & NHLBI, Health Scientist Administrator
Blood Resources Program, Division of Blood Diseases and Resources
- Overview of the PACT Program, William Reed, M.D., PACT Steering Committee Chair & Assistant Medical Director Research Blood Centers of the Pacific, Irwin Center, Blood Systems Research Institute
Methods and Protocols Presently Active at:
- Baylor College of Medicine, Catherine Bollard, M.D., Assistant Professor of Pediatrics and Medicine, Center for Cell and Gene Therapy
“The Use Of Donor-Derived Virus-specific Cytotoxic T Lymphocytes Post Stem Cell Transplant”
- University of Pittsburgh, Joseph Kiss, M.D., Medical Director, Hemapheresis and Blood Services, Institute for Transfusion Medicine, Associate Professor of Medicine “Use of Bone Marrow-derived Progenitor Cells in Cardiac Repair and Regeneration”
- University of Minnesota, David McKenna, M.D., Assistant Professor, Lab. Med. & Path., Assistant Medical Director, Clinical Cell Therapy Laboratory
“Adjunctive Cellular Immunotherapy in Bone Marrow Transplantation”
- Process for Making Proposals to PACT, Debbie Wood, MT (ASCP), Regulatory Specialist, The EMMES Corporation
- Panel Discussion
PACT will be offering attendees the opportunity to complete a survey regarding needs of the cell therapy community. The results of the survey will have a significant influence on the way PACT develops its initiatives. All stakeholders in the cell therapy community are invited to participate.
We are looking forward to your attendance. If you have any questions about this program, please contact us.
The PACT Group is an NHLBI-funded initiative that is committed to the advancement of effective cell therapies. PACT supports the development of novel somatic cell therapy products by providing production assistance to the cell therapy community, as well as educational training via web seminars and at meetings. Production assistance is provided through the funded contract manufacturing of therapeutic cell products at PACT processing facilities. These facilities offer scale-up capability and expertise in the translational development needed to produce cell therapy products under cGMP and cGTP regulations. PACT manufactures quality cell therapy products on behalf of investigators with funded clinical trials requiring support in product development and approval. PACT’s educational training focuses on three general areas: translational development/scale-up and manufacture of cell therapy products; and quality assurance and regulatory issues.
This project has been funded in whole or in part with Federal funds from the NHLBI, NIH under Contract No. NO1-HB37166.
# # #